Skip to main content
Log in

Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins

  • Short Original Communications
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

The substantia nigra (SN) in 11 Parkinson's disease (PD) patients and 5 neurologically normal controls was examined immunohistochemically using antibodies to various proteins of the complement system. In PD, but not in control SN, intra-and extraneuronal Lewy bodies and dendritic spheroid bodies were stained with anti-human C3d, C4d, C7 and C9 antibodies, but not with antibodies to C1q, fraction Bb of factor B or properdin. Axonal spheroid bodies in the nigrostriatal tract were not stained by any of the complement antibodies. However, complement-activated oligodendroglia were revealed by anti-C3d and anti-C4d antibodies in the PD substantia nigral area. These data indicate that some pathological structures in PD activate the classical complement pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bancher C, Lassmann H, Budka H, et al (1989) An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 48:81–93

    Google Scholar 

  2. Forno LS (1990) Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In: Stern G (ed) Parkinson's disease. The Johns Hopkins University Press, Baltimore, pp 185–238

    Google Scholar 

  3. Galloway PG, Grundke-Iqbal I, Iqbal K, Perry G (1988) Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol 47:654–663

    Google Scholar 

  4. Gibb WRG (1987) The epidemiology of Lewy bodies. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, New Jersey, pp 1–13

    Google Scholar 

  5. Goldman JE, Yen SH (1983) Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221:1082–1084

    Google Scholar 

  6. Leigh PN, Probst A, Dale GE, et al (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 79:61–72

    Google Scholar 

  7. Love S, Saitoh T, Quijada S, Cole GM, et al (1989) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 147:393–405

    Google Scholar 

  8. Lowe J, McDermott H, Landon M, et al (1990) Ubiquitin carboxyl-teminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153–160

    Google Scholar 

  9. McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574–576

    Google Scholar 

  10. McGeer PL, Akiyama H, Itagaki S, McGeer EG (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 107:341–346

    Google Scholar 

  11. Morgan BP (1989) Complement membrane attack on nucleated cells: resistence, recovery and non-lethal effects. Biochem J 264:1–14

    Google Scholar 

  12. Nakashima S, Ikuta F (1984) Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains. J Neurol Sci 66:91–96

    Google Scholar 

  13. Papolla MA (1986) Lewy bodies of Parkinson's disease. Arch Pathol Lab Med 110:1160–1163

    Google Scholar 

  14. Yamada T, Akiyama H, McGeer PL (1990) Complementactivated oligodendroglia: a new pathological entity identified by immunostaining with antibodies to human complement proteins C3d and C4d. Neurosci Lett 112:161–166

    Google Scholar 

  15. Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D 28K. Brain Res 526:303–307

    Google Scholar 

  16. Yamada T, Akiyama H, McGeer PL (1991) Two types of spheroid bodies in the nigral neurons in Parkinson's disease. Can J Neurol Sci 18:287–294

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants from the Medical Research Council of Canada and the Parkinson's Disease Foundation of Canada, as well as donations from individual British Columbians.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, T., McGeer, P.L. & McGeer, E.G. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol 84, 100–104 (1992). https://doi.org/10.1007/BF00427222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427222

Key words

Navigation